Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
10/15/1997 | EP0800824A1 Stable carotenoid emulsions for parenteral administration |
10/15/1997 | EP0800815A2 Use of at least one lypoxygenase inhibitor and at least one cyclo-oxygenase inhibitor to alter hair growth |
10/15/1997 | EP0800533A1 Anti-inflammatory cd14 peptides |
10/15/1997 | EP0800531A2 Novel receptor tyrosine kinases |
10/15/1997 | EP0800530A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
10/15/1997 | EP0800524A1 6- triazolyl 3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones |
10/15/1997 | EP0800514A1 Substituted imides as tnf inhibitors |
10/15/1997 | EP0800510A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
10/15/1997 | EP0800505A1 Novel immunotherapeutic aryl amides |
10/15/1997 | EP0800504A1 Tricyclic retinoids, methods for their production and use |
10/15/1997 | EP0800503A1 Novel trienoic retinoid compounds and methods |
10/15/1997 | EP0800405A1 Continuous low-dose administration of parathyroid hormone or its agonist |
10/15/1997 | EP0800397A1 Bone mass anabolic composition comprising olpadronate |
10/15/1997 | EP0800389A1 Novel compounds |
10/15/1997 | EP0800388A1 Compounds for veterinary and medicinal applications |
10/15/1997 | EP0800387A1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
10/15/1997 | EP0642583B1 Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
10/15/1997 | EP0573542B1 Imidazole-derivatives having antagonistic activity on the histamine h3-receptor |
10/15/1997 | EP0546102B1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
10/15/1997 | CN1161960A Ortho-substituted benzoylguanidine, preparation method, use as medicine or diagnostic reagent and medicine containing same |
10/15/1997 | CN1161860A Xuerong medicinal liquor and preparation method thereof |
10/15/1997 | CN1161848A Capsule for giving up drug-taking |
10/14/1997 | US5677331 Antimalarial compositions |
10/14/1997 | US5677328 Ethylamino carbazole melatonergic agents |
10/14/1997 | US5677325 Administering as partial agonist of the glycine b site; for treatment of convulsion, alzheimer's disease, huntingtons's chorea, anxiety |
10/14/1997 | US5677324 Benzopyranes as potassium channel openers |
10/14/1997 | US5677322 Therapy for aging, diabetes |
10/14/1997 | US5677320 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
10/14/1997 | US5677319 Thiazole derivative |
10/14/1997 | US5677317 Lactam compounds which are useful in the treatment of asthma |
10/14/1997 | US5677312 Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation |
10/14/1997 | US5677311 Serotonin antagonism and acetylcholine release accelerating action; antiemetic and oxiolytic agent |
10/14/1997 | US5677302 Antiulcer agent |
10/14/1997 | US5677298 Benzoxazepine-2-one compounds and their use |
10/14/1997 | US5677297 Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
10/14/1997 | US5677293 16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors |
10/14/1997 | US5677283 Antiinflammatory agents, nervous system disorders |
10/14/1997 | US5677282 Amino acid amides of 1,3,4-thiadiazoles as matrix metalloproteinase |
10/14/1997 | US5677278 Truncated keratinocyte growth factor (KGF) having increased biological activity |
10/14/1997 | US5677176 Animal derived cell with antigenic protein introduced therein |
10/14/1997 | US5677171 Inhibit growth of sk-br-3 breast tumor cells |
10/14/1997 | US5677165 Anti-CD40 monoclonal antibodies capable of blocking B-cell activation |
10/14/1997 | US5677149 Culturing under suitable conditions a host cell transformed or trasnfected with a replicable vector comprising specific nucleic acid sequence in a manner allowing expression of the polypeptide and recovering transformed polypeptide |
10/14/1997 | US5676957 Skin external agent |
10/14/1997 | US5676941 Methods of enhancing bone marrow transplantation and treating burn wounds comprising administering human pluripotent granulocyte colony-stimulating factor |
10/09/1997 | WO1997037043A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q |
10/09/1997 | WO1997037037A1 Phosphatase modulator |
10/09/1997 | WO1997037030A1 Method of screening dna-binding protein, plasmid to be used therefor, and dna-binding protein |
10/09/1997 | WO1997037026A1 Novel compounds |
10/09/1997 | WO1997037020A1 Apo-2li and apo-3 apoptosis polypeptides |
10/09/1997 | WO1997037016A1 Modulators of tnf receptor associated factor (traf), their preparation and use |
10/09/1997 | WO1997037015A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |
10/09/1997 | WO1997037002A1 Promotion of regeneration of organized tissues |
10/09/1997 | WO1997036929A1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
10/09/1997 | WO1997036922A1 Inhibitor and stimulator of stem cell proliferation and uses thereof |
10/09/1997 | WO1997036919A2 Cytokine designated lerk-8 |
10/09/1997 | WO1997036907A1 Benzoxazines for enhancing synaptic response |
10/09/1997 | WO1997036906A1 Heterocyclic compounds and their preparation and use |
10/09/1997 | WO1997036905A1 Diazepino-indoles as phosphodiesterase iv inhibitors |
10/09/1997 | WO1997036904A1 Mitomycin c derivative and non-receptor tyrosine kinase inhibitor |
10/09/1997 | WO1997036903A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
10/09/1997 | WO1997036901A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036900A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036898A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036897A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036896A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036893A1 Piperazine and piperidine compounds |
10/09/1997 | WO1997036891A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036890A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036889A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036888A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036886A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036885A1 Thiazoline acid derivatives |
10/09/1997 | WO1997036879A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036875A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036874A1 Eprosartan dihydrate and a process for its production and formulation |
10/09/1997 | WO1997036871A1 6-phenylpyridyl-2-amine derivatives |
10/09/1997 | WO1997036869A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity |
10/09/1997 | WO1997036867A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
10/09/1997 | WO1997036863A1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors |
10/09/1997 | WO1997036862A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
10/09/1997 | WO1997036861A1 Meta-substituted phenylene sulphonamide derivatives |
10/09/1997 | WO1997036858A1 Cyclopropyl alkanoic acid derivatives |
10/09/1997 | WO1997036853A1 Dimethyl-substituted cyclohexane diene derivatives |
10/09/1997 | WO1997036605A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036594A1 Vitamin b2-containing medicines |
10/09/1997 | WO1997036593A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036592A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036591A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036585A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036580A1 Amidinohydrazones as protease inhibitors |
10/09/1997 | WO1997036547A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
10/09/1997 | WO1997036497A2 Cocoa extract compounds and methods for making and using the same |
10/09/1997 | WO1997021820A3 A novel protein kinase required for ras signal transduction |
10/09/1997 | CA2250936A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2250843A1 Heterocyclic compounds and their preparation and use |
10/09/1997 | CA2250695A1 Cyclopropyl alkanoic acid derivatives |
10/09/1997 | CA2250587A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2250464A1 Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors |
10/09/1997 | CA2250353A1 Inhibitors of farnesyl-protein transferase |